Niki BioSolutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Niki BioSolutions, Inc. (NIKI) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 0.69% for the 12-month period ending 2020-12-31, per its 20-F/A filed 2023-01-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2023-01-17
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 10 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | 0.69% 20-F/A · filed 2023-01-17 | ||||
| 2020-06-30 | 0.69% 6-K · filed 2021-09-15 | 2.49% 6-K · filed 2020-09-02 | |||
| 2019-12-31 | 2.49% 20-F/A · filed 2023-01-17 | 2.82% 20-F · filed 2020-04-29 | |||
| 2018-12-31 | 2.82% 20-F · filed 2019-04-15 | ||||
| 2017-12-31 | 2.82% 20-F · filed 2019-04-15 |